A very recent study analysing the phosphoproteome of six human pancreatic cancer cell lines using the ERK1/2-selective inhibitor SCH772984 at two different time points did not reveal an obvious regulation of pT401 by ERK [44]. This evidence concerns the gene MAPK3 and pancreatic neoplasm.